1.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BB-C03/IVB/128, NCI-V96-0908
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BB-C03/IVB/131, NCI-V96-0909
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BB-C03/IVB/140, NCI-V96-0910
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ILEX-C03-IVB/173, BB-C03-IVB/173, NCI-V96-1113, NCT00002911
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065585, E2196, NCCTG-E2196, NCT00003010
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Other
Protocol IDs: BR12, EORTC-08962, CAN-NCIC-BR12, EORTC-08962B, CDR0000065589, NCT00003011
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95044A1, NCI-V95-0751
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND91, NCI-V95-0757, IND91
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: BB-C03-IVB-172, NCI-V96-1112
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BB-C03/IVB/185, NCI-V97-1265
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BB-C03/IVB/187, NCI-V97-1266
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BRUOG-PA-68, NCI-V98-1392
|
Mobile | Español
